Community-based Microalbuminuria Screening in Patients With Hypertension (CMSIH)
Status
Conditions
Details and patient eligibility
About
This study evaluates the effectiveness of different anti-hypertensive drugs on patients with hypertension and microalbuminuria.
Full description
This is a a real world registry study. All patients with hypertension in community hospitals in China will be eligible . Patient demographics, medical history, clinical characteristics, physical examination, laboratory tests (including UCAR, blood routine, urine routine, blood biochemistry, and ECG), antihypertensive drugs (including: ACEI/ ARB, thiazide diuretics, CCB, beta-blockers, alpha-blockers, and other antihypertensive drugs used in real-life clinical practice in other communities.) will be recorded. All patients are anticipated to be followed up for 12-month. Effectiveness of different antihypertensive medications on Urine Albumin-to-Creatinine Ratio (UACR) will be evaluted.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients with essential hypertension;
- Urinary albumin/creatinine ratio in random urine samples is 30-300 mg/g
- Age >=18
- Understand and sign informed consent
Exclusion criteria
- This is a real-world registry study and does not set exclusion criteria
Trial contacts and locations
Loading...
Central trial contact
Wei Zhang, phD; Xuejuan Jin, MS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal